Vertex Pharmaceuticals Inc (VRTX) Monthly Backtest Results
Backtest Summary
This table summarises how profitable it would have been to have bought this stock at each monthly entry signal. The compound annual growth rate (CAGR) shows the profitability of the trade on an annualised basis.
| Entry Date | Exit Date | Profit or Loss | CAGR |
|---|---|---|---|
| 03 March 2025 | 02 June 2025 | -7.74% | -27.62% |
| 01 May 2023 | 02 January 2025 | 18.05% | 10.42% |
| 01 February 2022 | 01 March 2023 | 18.90% | 17.44% |
| 02 December 2019 | 02 November 2020 | -5.68% | -6.15% |
| 01 March 2019 | 01 May 2019 | -10.66% | -49.07% |
| 01 August 2018 | 02 January 2019 | -7.88% | -17.79% |
| 01 March 2017 | 01 June 2018 | 68.53% | 51.72% |
| 01 September 2016 | 03 October 2016 | -8.71% | -64.64% |
| Total Return | 64.80% | ||
The monthly data for Vertex Pharmaceuticals Inc (exchange: XNAS symbol: VRTX) was last updated 27 Dec 2025 05:20. Data for this stock is available from 01 Dec 2015 - 26 Dec 2025.
